Weiyi Peng to Melanoma
This is a "connection" page, showing publications Weiyi Peng has written about Melanoma.
Connection Strength
1.073
-
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma. J Invest Dermatol. 2023 Sep; 143(9):1779-1787.e1.
Score: 0.198
-
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma. Clin Cancer Res. 2023 Jan 04; 29(1):154-164.
Score: 0.196
-
Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors. Sci Adv. 2022 Mar 04; 8(9):eabm1032.
Score: 0.185
-
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies. Mol Cancer Ther. 2021 Mar; 20(3):500-511.
Score: 0.170
-
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity. Cancer Immunol Immunother. 2021 Apr; 70(4):1101-1113.
Score: 0.168
-
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma. Clin Cancer Res. 2019 Nov 01; 25(21):6429-6442.
Score: 0.155